Evidence map›Paper›PMID 39769632›Full record

ArticleMaterials (Basel, Switzerland)2024

Fine Tuning the Glass Transition Temperature and Crystallinity by Varying the Thiophene-Quinoxaline Copolymer Composition.

Xun Pan, Mats R Andersson

Abstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Linking the Evolution of Raman-Active Vibrational Modes to the Glass Transition of a Polymer Mixed Conductor.Chemistry of materials : a publication of the American Chemical Society · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Xun PanFlinders Institute for NanoScale Science and Technology, College of Science and Engineering, Flinders University, Sturt Road, Bedford Park, Adelaide, SA 5042, Australia.ORCID 0000-0001-6087-7363
Mats R AnderssonFlinders Institute for NanoScale Science and Technology, College of Science and Engineering, Flinders University, Sturt Road, Bedford Park, Adelaide, SA 5042, Australia.

Funding

Australian Research Council DP220102900
6 · The paper itself

Abstract

In recent years, the design and synthesis of high-performing conjugated materials for the application in organic photovoltaics (OPVs) have achieved lab-scale devices with high power conversion efficiency. However, most of the high-performing materials are still synthesised using complex multistep procedures, resulting in high cost. For the upscaling of OPVs, it is also important to focus on conjugated polymers that can be made via fewer simple synthetic steps. Therefore, an easily synthesised amorphous thiophene-quinoxaline donor polymer, TQ1, has attracted our attention. An analogue, TQ-EH that has the same polymer backbone as TQ1 but with short branched side-chains, was previously reported as a donor polymer with increased crystallinity. We have synthesised copolymers with varied ratios between octyloxy and branched (2-ethylhexyl)oxy-substituted quinoxaline units having the same polymer backbone, with the aim to control the aggregation/crystallisation behaviour of the resulting copolymers. The optical properties, glass transition temperatures and degree of crystallinity of the new copolymers were systematically examined in relation to their copolymer composition, revealing that the composition can be used to fine-tune these properties of conjugated polymers. In addition, multiple sub-

Indexed as

conjugated polymerscopolymer compositioncrystallinityglass transition temperaturesorganic photovoltaicsside-chain modification

Identifiers

PMID39769632
PMCPMC11676980

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.